builderall

CONFERENCE INFORMATION

SUMMIT DESCRIPTION

At the vibrant crossroads of the Americas, Panama City will host a high-impact, two-day immersion in thoracic oncology. Summit Directors Franklin Castillero, MD, Luis Alberto Corrales, MD, Luis E. Raez, MD, and Edgardo S. Santos, MD, in partnership with The Medical Educator Consortium (MEC), will convene MaTOS LATAM Panama (Masters in Thoracic Oncology Summit) on August 28–29, 2026 at the Hotel Riu Plaza Panama. Expect timely science, pragmatic cases, and cross-border collaboration—all designed to elevate practice and outcomes across the region.

 

Join us in Panama City pairs where a soaring skyline with a UNESCO-listed historic quarter, the Panama Canal, and the rare treat of an urban rainforest inside city limits. The city’s multicultural roots—Indigenous, Afro-Panamanian, Latin, and global—shape its food, music, and welcoming social culture you’ll feel in plazas, markets, and cafés. Highlights near the venue: the Miraflores Visitor Center at the Canal, Casco Antiguo (Old Quarter), Biomuseo by Frank Gehry on the Amador Causeway, the waterfront Cinta Costera, and Metropolitan Natural Park for skyline overlooks and wildlife. Culture & arts: Galleries, street art, and museums cluster in Casco Viejo and nearby districts; the city’s mix of traditions shows up in cuisine and festivals.

CONFERENCE DESCRIPTION

Masters in Thoracic Oncology Summit (MaTOS Lung) | Latin-America (LATAM) is a dynamic 2-day conference led by experts in thoracic oncology. This summit delivers in-depth, multidisciplinary discussions on the most pressing challenges and future directions in lung cancer care. Participants will explore cutting-edge advances in molecular profiling, immunotherapy, targeted therapy, liquid biopsies & minimal residual disease (MRD), as well as emerging technologies in lung cancer screening, tumor monitoring, and therapy. The MaTOS Lung conferences have been a success in the United States in the last 3 years, being regarded as the best lung cancer conferences. Engaging panel sessions and case-based dialogues will emphasize the integration of new data into current standards of care, including the classification and clinical application of adjuvant and neoadjuvant therapies. Attendees will leave with actionable insights that can immediately implement in their practice and improve patient outcomes. Our Key Opinion Leaders (KOLs) will include the best Latin American thoracic oncologists and KOLs from the United States.

KEY POINTS INCLUDE:

  • Emerging therapeutic strategies in thoracic oncology, including targeted agents and immunotherapies.

  • Implementation of lung cancer screening programs using imaging, liquid biopsies, and novel biomarkers.

  • Multidisciplinary evaluation of new clinical data and its integration into treatment pathways for early-stage and locally advanced non-small cell lung cancers.

  • Critical appraisal of newly approved agents and evolving standards in metastatic and early-stage disease.

  • New developments in the management of limited and extensive small cell lung cancers.

  • Adverse events challenges and management review of new bispecifics, antibody drug conjugates and T-cell engagers.

  • Review of mechanisms of resistant of the most common targeted therapies and checkpoint inhibitors, and new strategies to treat and improve immune response.

TARGET AUDIENCE & EXPECTED ATTENDANCE

This educational activity is intended for physicians, advanced practice providers (nurse practitioners, physician associates), and other healthcare professionals involved in the care of patients with thoracic malignancies, including but not limited to medical oncologists, surgical oncologists, radiation oncologists, pulmonologists, pathologists, radiologists, and oncology pharmacists. We expect 100-125 attendees to participate in this noteworthy summit.